Naloxegol US PMR CV Safety.

Trial Identifier:	D3820R00008
Sponsor:	AstraZeneca
NCTID::	NCT02813356
Start Date:	June 2016
Primary Completion Date:	December 2023
Study Completion Date:	December 2023
Condition:	Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, DE	Wilmington, DE, USA, 19803
USA, IL	Hines, IL, USA, 60141

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.